Back to Results
First PageMeta Content
Pharmaceutical sciences / Prescription Drug User Fee Act / FDA Special Protocol Assessment / Priority review voucher / Food and Drug Administration / Health / Medicine


Document Date: 2005-09-14 09:31:45

Open Document

File Size: 423,70 KB

Share Result on Facebook

City

Washington / DC / Washington / D.C. / /

Company

Performance Goals Under PDUFA / PDUFA User Fees United States / PDUFA User Fees / IMS Health / Biologic Review / /

Continent

America / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / Product Recall / Product Issues / /

Facility

National Institute / /

IndustryTerm

health provider groups / biotechnology industries / blood products / drug manufacturing changes / pharmaceuticals / treatment of rare diseases / biologic applications / drug products / /

MedicalCondition

rare diseases / /

MedicalTreatment

angioplasty / drug therapies / /

Organization

National Institute of Health / FOOD AND DRUG ADMINISTRATION / office of Personnel Management Prescription Drug User Fee Act Pharmaceutical Research and Manufacturers of America GAO-02-958 PDUFA User Fees United States General Accounting office Washington / Committee on Health / Education / Labor / and Pensions / National Institute for Health Care Management / office of the Associate / Consumer Federation of America / United States Senate / Congress / Radiological Health / and National Center for Toxicological Research / federal government / Center for Biologics Evaluation / Center for Devices and Radiological Health / National Center for Toxicological Research / Centers for Disease Control and Prevention Center for Drug Evaluation and Research Food and Drug Administration Food and Drug Administration Modernization Act / Biotechnology Industry Organization / Food Safety / Department of Health and Human Services / Center for Veterinary Medicine / office of Personnel Management / Honorable Edward M. Kennedy Chairman Committee on Health / Education / Labor / and Pensions United States Senate Dear / /

Position

Secretary of Health / General / Secretary / Chairman / Commissioner for Planning / /

Product

4 18 24 28 29 Drugs / rates / rate / Priority Drug / Safety-Related Drug / GAO-02-958 / Standard New Drug / new drug / FDA / /

ProgrammingLanguage

DC / /

Technology

Biotechnology / drug development / /

SocialTag